About Us Our BioBank Platform Technology Our Drug Programmes News Contact us Collaboration Opportunities INVESTORS NEWS Our specialist approach to drug discovery and development in the respiratory disease area is validated by the collaborations we have already formed. Our partners have been particularly attracted to Synairgen because of our advanced in vitro human cell models of disease. If your company might benefit from Synairgen’s specialist drug discovery and development capabilities, please contact us at partners@synairgen.com We are looking to in-license or partner programmes which have potential utility in asthma, COPD or other lung diseases. In particular we would like to apply our BioBank model platform and clinical competence to new opportunities. Synairgen plc Registered in England and Wales No. 5233429 Registered office Mailpoint 810, Level F, South Block, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK